Our ultimate research vision is to discover, develop and implement novel neuroprotective and neurorestorative therapies for neurological disorders such as Parkinsons disease, Huntingtons disease and stroke.
My group works with translational research that is tightly linked to clinical research questions. Our experimental focus is to understand neurovascular disease mechanisms. We examine the dysfunction of the neurovascular unit, in particular pericytes, as key players in inflammation and neurodegeneration and as potential target cells for brain repair using in vitro and in vivo disease modeling and also clinical material.
We work on cell target identification for brain repair, on novel restorative molecules as well as on the clinical implementation of stem cell and different growth factor therapies for Parkinsons disease